Medindia

X

Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)

Tuesday, December 22, 2009 Corporate News J E 4
Advertisement
Comvita Grants Perpetual Rights To This Highly Successful Wound Care Dressing For Medical And Professional Markets

Contact:

Derma Sciences, Inc.

Edward J. Quilty

Chairman and CEO

equilty@dermasciences.com

(609) 514-4744

The Investor Relations Group

212-825-3210

Jason Strominger (Investor Relations)

Janet Vasquez (Media Relations)

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mylan Confirms First-to-File Patent Challenge Rela...
S
Arrayit Corporation Announces Manufacturing Breakt...